Brandywine Global Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-414,084
| Closed | -$2.51M | – | 700 |
|
|
2023
Q4 | $2.51M | Sell |
414,084
-43,250
| -9% | -$263K | 0.02% | 519 |
|
|
2023
Q3 | $1.93M | Buy |
457,334
+55,654
| +14% | +$235K | 0.02% | 553 |
|
|
2023
Q2 | $1.25M | Buy |
+401,680
| New | +$1.25M | 0.01% | 607 |
|
|
2022
Q4 | – | Sell |
-188,559
| Closed | -$381K | – | 724 |
|
|
2022
Q3 | $381K | Sell |
188,559
-9,083
| -5% | -$18.4K | ﹤0.01% | 687 |
|
|
2022
Q2 | $629K | Sell |
197,642
-10,825
| -5% | -$34.5K | 0.01% | 649 |
|
|
2022
Q1 | $869K | Buy |
208,467
+11,744
| +6% | +$49K | 0.01% | 633 |
|
|
2021
Q4 | $942K | Hold |
196,723
| – | – | 0.01% | 585 |
|
|
2021
Q3 | $1.05M | Buy |
196,723
+25,808
| +15% | +$138K | 0.01% | 570 |
|
|
2021
Q2 | $875K | Sell |
170,915
-4,898
| -3% | -$25.1K | 0.01% | 576 |
|
|
2021
Q1 | $1.18M | Sell |
175,813
-9,375
| -5% | -$63.1K | 0.01% | 553 |
|
|
2020
Q4 | $846K | Buy |
+185,188
| New | +$846K | 0.01% | 533 |
|